Singapore’s Bio*One Capital Eyes Services, Data and Devices In Investment Push: An Interview With PharmAsia News
This article was originally published in PharmAsia News
Executive Summary
The biomedical investment arm of Singapore’s state-run investment firm EDBI, gives PharmAsia News insight into where its next round of investments are aimed.